Advertisement

Atrial fibrillation and cognitive decline in the Framingham Heart Study

Published:September 21, 2017DOI:https://doi.org/10.1016/j.hrthm.2017.09.036

      Background

      There is a paucity of longitudinal research investigating the relations between atrial fibrillation (AF) and domain-specific cognitive performance.

      Objective

      The purpose of this study was to investigate the association between AF and cognitive performance cross-sectionally and longitudinally.

      Methods

      Eligible participants were dementia- and stroke-free at the time of baseline neuropsychological (NP) assessment and underwent at least 1 additional NP assessment with at least 1-year inter-test interval. AF status was examined as a 2-level variable (prevalent AF, no AF) in cross-sectional analyses and then separately as a 3-level variable (prevalent AF, interim AF, no AF) in longitudinal analyses. We examined the association between AF status and cognitive performance with linear regression. We first adjusted models for age and sex and then for vascular risk factors and apolipoprotein ε4 (APOE4) status.

      Results

      We studied 2682 participants of the Framingham Heart Study original and offspring cohorts. At the baseline NP assessment, 112 participants (4%) had AF (mean age 72 ± 9 years; 32% women). After adjustment for vascular risk factors and APOE4 status, prevalent AF was significantly associated with poorer attention; sex differences were also noted with men performing worse on tests of abstract reasoning and executive function, while women did better on a measure of executive function. Prevalent AF was significantly associated with longitudinal decline in executive function in the original cohort, and interim AF was significantly associated with longitudinal decline in executive function in the offspring cohort.

      Conclusion

      After accounting for vascular risk factor burden and APOE4 status, AF was associated with a vascular profile of change in cognitive function.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Piccini J.P.
        • Hammill B.G.
        • Sinner M.F.
        • Jensen P.N.
        • Hernandez A.F.
        • Heckbert S.R.
        • Benjamin E.J.
        • Curtis L.H.
        Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.
        Circ Cardiovasc Qual Outcomes. 2012; 5: 85-93
        • Colilla S.
        • Crow A.
        • Petkun W.
        • Singer D.E.
        • Simon T.
        • Liu X.
        Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population.
        Am J Cardiol. 2013; 112: 1142-1147
        • Piccini J.P.
        • Hammill B.G.
        • Sinner M.F.
        • Hernandez A.F.
        • Walkey A.J.
        • Benjamin E.J.
        • Curtis L.H.
        • Heckbert S.R.
        Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke.
        Eur Heart J. 2014; 35: 250-256
        • Marzona I.
        • O’Donnell M.
        • Teo K.
        • Gao P.
        • Anderson C.
        • Bosch J.
        • Yusuf S.
        Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies.
        Can Med Assoc J. 2012; 184: E329-E336
        • Knecht S.
        • Oelschläger C.
        • Duning T.
        • Lohmann H.
        • Albers J.
        • Stehling C.
        • Heindel W.
        • Breithardt G.
        • Berger K.
        • Ringelstein E.B.
        • Kirchhof P.
        • Wersching H.
        Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy.
        Eur Heart J. 2008; 29: 2125-2132
        • Elias M.F.
        • Sullivan L.M.
        • Elias P.K.
        • Vasan R.S.
        • D’Agostino Sr., R.B.
        • Seshadri S.
        • Au R.
        • Wolf P.A.
        • Benjamin E.J.
        Atrial fibrillation is associated with lower cognitive performance in the Framingham offspring men.
        J Stroke Cerebrovasc Dis. 2006; 15: 214-222
        • de Bruijn R.F.
        • Heeringa J.
        • Wolters F.J.
        • Franco O.H.
        • Stricker B.H.
        • Hofman A.
        • Koudstaal P.J.
        • Ikram M.A.
        Association between atrial fibrillation and dementia in the general population.
        JAMA Neurol. 2015; 72: 1288-1294
        • Santangeli P.
        • Di Biase L.
        • Bai R.
        • Mohanty S.
        • Pump A.
        • Cereceda Brantes M.
        • Horton R.
        • Burkhardt J.D.
        • Lakkireddy D.
        • Reddy Y.M.
        • Casella M.
        • Dello Russo A.
        • Tondo C.
        • Natale A.
        Atrial fibrillation and the risk of incident dementia: a meta-analysis.
        Heart Rhythm. 2012; 9: 1761-1768
        • Bunch T.J.
        • Weiss J.P.
        • Crandall B.G.
        • May H.T.
        • Bair T.L.
        • Osborn J.S.
        • Anderson J.L.
        • Muhlestein J.B.
        • Horne B.D.
        • Lappe D.L.
        • Day J.D.
        Atrial fibrillation is independently associated with senile, vascular, and Alzheimer’s dementia.
        Heart Rhythm. 2010; 7: 433-437
        • Farina E.
        • Magni E.
        • Ambrosini F.
        • Manfredini R.
        • Binda A.
        • Sina C.
        • Mariani C.
        Neuropsychological deficits in asymptomatic atrial fibrillation.
        Acta Neurol Scand. 1997; 96: 310-316
        • O’Connell J.E.
        • Gray C.S.
        • French J.M.
        • Robertson I.H.
        Atrial fibrillation and cognitive function: case-control study.
        J Neurol Neurosurg Psychiatry. 1998; 65: 386-389
        • Kalantarian S.
        • Stern T.A.
        • Mansour M.
        • Ruskin J.N.
        Cognitive impairment associated with atrial fibrillation.
        Ann Intern Med. 2013; 158: 338-346
        • Kilander L.
        • Andrén B.
        • Nyman H.
        • Lind L.
        • Boberg M.
        • Lithell H.
        Atrial fibrillation is an independent determinant of low cognitive function: a cross-sectional study in elderly men.
        Stroke. 1998; 29: 1816-1820
        • Ott A.
        • Breteler M.M.
        • de Bruyne M.C.
        • van Harskamp F.
        • Grobbee D.E.
        • Hofman A.
        Atrial fibrillation and dementia in a population-based study: the Rotterdam Study.
        Stroke. 1997; 28: 316-321
        • Elias M.F.
        • Sullivan L.M.
        • D’Agostino R.B.
        • Elias P.K.
        • Beiser A.
        • Au R.
        • Seshadri S.
        • DeCarli C.
        • Wolf P.A.
        Framingham stroke risk profile and lowered cognitive performance.
        Stroke. 2004; 35: 404-409
        • Feinleib M.
        • Kannel W.B.
        • Garrison R.J.
        • McNamara P.M.
        • Castelli W.P.
        The Framingham offspring study: design and preliminary data.
        Prev Med. 1975; 4: 518-525
        • Seshadri S.
        • Beiser A.
        • Au R.
        • et al.
        Operationalizing diagnostic criteria for Alzheimer’s disease and other age-related cognitive impairment—Part 2.
        Alzheim Demen. 2011; 7: 35-52
        • Au R.
        • Seshadri S.
        • Wolf P.A.
        • Elias M.
        • Elias P.
        • Sullivan L.
        • Beiser A.
        • D'Agostino R.B.
        New norms for a new generation: cognitive performance in the Framingham offspring cohort.
        Exp Aging Res. 2004; 30: 333-358
        • Gunning-Dixon F.M.
        • Raz N.
        Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study.
        Neuropsychologia. 2003; 41: 1929-1941
        • Yang Y.
        • Raine A.
        Prefrontal structural and functional brain imaging findings in antisocial, violent, and psychopathic individuals: a meta-analysis.
        Psychiatry Res. 2009; 174: 81-88
        • Zinn S.
        • Bosworth H.B.
        • Hoenig H.M.
        • Swartzwelder H.S.
        Executive function deficits in acute stroke.
        Arch Phys Med Rehabil. 2007; 88: 173-180
        • Au R.
        • Massaro J.M.
        • Wolf P.A.
        • Young M.E.
        • Beiser A.
        • Seshadri S.
        • D’Agostino R.B.
        • DeCarli C.
        Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study.
        Arch Neurol. 2006; 63: 246-250
        • Hochstenbach J.
        • Mulder T.
        • van Limbeek J.
        • Donders R.
        • Schoonderwaldt H.
        Cognitive decline following stroke: a comprehensive study of cognitive decline following stroke.
        J Clin Exp Neuropsychol. 1998; 20: 503-517
        • Rasquin S.M.
        • Verhey F.R.
        • Lousberg R.
        • Lodder J.
        Cognitive performance after first ever stroke related to progression of vascular brain damage: a 2 year follow up CT scan study.
        J Neurol Neurosurg Psychiatry. 2005; 76: 1075-1079
        • Prins N.D.
        • Scheltens P.
        White matter hyperintensities, cognitive impairment and dementia: an update.
        Nat Rev Neurol. 2015; 11: 157-165
        • Kaffashian S.
        • Dugravot A.
        • Nabi H.
        • Batty G.D.
        • Brunner E.
        • Kivimäki M.
        • Singh-Manoux A.
        Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II study.
        Eur Heart J. 2011; 32: 2326-2332
        • Muller M.
        • van der Graaf Y.
        • Visseren F.L.
        • Vlek A.L.
        • Mali W.P.
        • Geerlings M.I.
        • SMART Study Group
        Blood pressure, cerebral blood flow, and brain volumes: the SMART-MR study.
        J Hypertens. 2010; 28: 1498-1505
        • Stirling J.
        • Muramatsu K.
        • Shirai T.
        Cerebral embolism as a cause of stroke and transient ischemic attack.
        Echocardiography. 1996; 13: 513-518
        • Wiseman R.M.
        • Saxby B.K.
        • Burton E.J.
        • Barber R.
        • Ford G.A.
        • O’Brien J.T.
        Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects.
        Neurology. 2004; 63: 1892-1907
        • Espeland M.A.
        • Bryan R.N.
        • Goveas J.S.
        • Robinson J.G.
        • Siddiqui M.S.
        • Liu S.
        • Hogan P.E.
        • Casanova R.
        • Coker L.H.
        • Yaffe K.
        • Masaki K.
        • Rossom R.
        • Resnick S.M.
        • WHIMS-MRI Study Group
        Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women’s Health Initiative Magnetic Resonance Imaging studies.
        Diabetes Care. 2013; 36: 90-97
        • Piers R.J.
        • Nishtala A.
        • Preis S.R.
        • DeCarli C.
        • Wolf P.A.
        • Benjamin E.J.
        • Au R.
        Association between atrial fibrillation and volumetric MRI brain measures: Framingham Offspring Study.
        Heart Rhythm. 2016; 13: 2020-2024
        • Joosten H.
        • van Eersel M.E.
        • Gansevoort R.T.
        • Bilo H.J.
        • Slaets J.P.
        • Izaks G.J.
        Cardiovascular risk profile and cognitive function in young, middle-aged, and elderly subjects.
        Stroke. 2013; 44: 1543-1549
        • Sadigh-Eteghad S.
        • Talebi M.
        • Farhoudi M.
        Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer’s disease, a meta-analysis.
        Neuroscience. 2012; 17: 321-326
        • DeCarli C.
        • Reed T.
        • Miller B.L.
        • Wolf P.A.
        • Swan G.E.
        • Carmelli D.
        Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study.
        Stroke. 1999; 30: 1548-1553
        • Stefansdottir H.
        • Arnar D.O.
        • Aspelund T.
        • Sigurdsson S.
        • Jonsdottir M.K.
        • Hjaltason H.
        • Launer L.J.
        • Gudnason V.
        Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarcts.
        Stroke. 2013; 44: 1020-1025